About MediWound Ltd.
MediWound Ltd. (Nasdaq: MDWD) is a global biotechnology company focused on developing and commercializing enzymatic therapies for non-surgical tissue repair.
MediWound Ltd. (MDWD) Stock Score & Signals
MediWound Ltd. (MDWD) trades on NASDAQ. It operates in the Health Care sector, Drug Manufacturers - Specialty & Generic industry. Its current 2BB score is 42 out of 100.
2BB score and signals
MediWound Ltd.’s current 2BB score is 42 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 33 | Low |
| Momentum | 50 | Stable |
| Financial strength | 7 | Very Weak |
| Quality | 87 | Very Strong |
| Risk | 38 | Low (provisional) |
Company facts
| CEO | Ofer Gonen |
| Founded | 2000 |
| Employees | 121 |
| 52-week range | $11.80 – $19.70 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-03-03 | — | -0.646 | — | $12.76M |
| 2026-11-12 | — | -0.7208 | — | $6.86M |